FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Windlas Biotech IPO.
August 4, 2021 4:30:00 AM
Windlas Biotech IPO opens on August 4 and closes on August 6. Demat account, trading application and UPI ID are mandatory if you are applying for an initial public offering (IPO). Windlas Biotech ...
Published by : Business Insider IndiaAugust 12, 2021 3:26:00 AM
Windlas Biotech is likely to announce its share allotment status on August 11. The company provides pharmaceutical development services and large-scale manufacturing services. The IPO of the ...
Published by : Business Insider IndiaSeptember 20, 2024 6:33:00 PM
EBITDA stands at Rs. 27.89 crore in September 2024 up 27.18% from Rs. 21.93 crore in September 2023.
Published by : moneycontrol.comMarch 24, 2023 3:07:00 PM
Windlas Biotech Ltd share price was up by 1.77% from the previous closing price of ?1,007.25. Who are peers of Windlas Biotech Ltd? The peers of Windlas Biotech Ltd are Sun Pharmaceuticals ...
Published by : Business TodayNovember 14, 2024 7:43:00 PM
Regarding breakout stocks to buy today, Sumeet Bagadia recommended buying these five shares: Windsor Machines, TTL, Suven Pharma, Paradeep Phosphates, and Windlas Biotech.
Published by : MintThe IPO Shares of Windlas Biotech Limited IPO are proposed to list on Monday, August 16, 2021 at BSE, NSE. The public issue of Windlas Biotech IPO was opened on Aug 4, 2021 and closed for subscription on Aug 6, 2021. Windlas Biotech IPO Listing Date and Information:
Listing Date | Monday, August 16, 2021 |
BSE Script Code | 543329 |
NSE Symbol | WINDLAS |
Listing In | |
ISIN | INE0H5O01029 |
Issue Price | ₹460 Per Equity Share |
Face Value | ₹5 Per Equity Share |
The allotment status of Windlas Biotech Limited IPO is now available online. The public issue of Windlas Biotech IPO was open on Aug 4, 2021 and closed for subscription on Aug 6, 2021. The equity shares of the company to be list at BSE, NSE.
The issue of Windlas Biotech Limited opens on Aug 4, 2021 and closes for subscription on Aug 6, 2021. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs 448- Rs 460 Per Equity Share.
Windlas Biotech Limited is entering in the capital market with an IPO of [.] Equity Shares of Rs 5 aggregating up to Rs 401.54 Crore. The price for the issue has been set at Rs 448-460 Rs Per Equity Share.
Incorporated in 2001, Windlas Biotech Ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.
The issue opens on Aug 4, 2021 and closes for subscription on Aug 6, 2021. The equity shares of the company to be list at BSE, NSE.
The Windlas Biotech IPO is proposed to open on August 4, 2021. The IPO application ends on August 6, 2021.
Retail investors can apply in the retail or non-institutional investor category from August 4, 2021 to August 6, 2021. The Windlas Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Windlas Biotech IPO will open for subscription on August 4, 2021. The public issue will close on August 6, 2021.
Useful Articles
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|